Study Summary
The goal of this study is to learn more about how the time in which participants consume their meals relative to their personalized circadian rhythm influences their overall cardiometabolic health and weight. The investigators are hoping to discover if a circadian-based time restricted eating intervention will improve cardiometabolic health and decrease weight. The protocol is a 46 day prospective cohort study that includes both field and in-laboratory data collection in overweight and obese individuals.
- Cardiometabolic Syndrome
- Weight Loss
- Circadian Rhythm
- Time-Restricted Feeding
- Cardiovascular Health
Treatment Effectiveness
Effectiveness Progress
Study Objectives
8 Primary · 3 Secondary · Reporting Duration: 7.5 hours
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control
1 of 2
Circadian Based Time Restricted Eating
1 of 2
Active Control
Experimental Treatment
10 Total Participants · 2 Treatment Groups
Primary Treatment: Circadian Based Time Restricted Eating · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 40 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Oregon | 100.0% |
What site did they apply to?
| Oregon Health and Science University | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "I gained a lot of weight during COVID and I think a big part of it was that my sleep schedule was very off due to my work situation and I was staying up until 4am or sometimes later. So I was eating late and I know everything was really off."
How many prior treatments have patients received?
| 0 | 100.0% |